TrialJournal of the National Cancer Institute2016

Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.

Stephanie R Land et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.